In a blind test, 344 samples representing 80 bacterial isolates were analyzed by the Brucella abortus species-specific polymerase chain reaction (BaSS PCR) assay for the identification and discrimination of B. abortus field strains (wild-type biovars 1, 2, and 4) from 1) B. abortus vaccine strains, 2) other Brucella species, and 3) non-Brucella bacteria. Identical samples were tested in 2 laboratories. Half the samples were fully viable, and half were bacteria that had been killed by methanol fixation. The results in 1 laboratory correctly identified 100% of the samples, resulting in a predictive value of 100% for all categories and 100% sensitivity and specificity under the prescribed conditions. The second laboratory misidentified 31 samples, resulting in a range of 66.7-100% sensitivity, 93.2-99.7% specificity, and 77.3-98.2% predictive values depending on the category. There was no significant difference in viable versus fixed bacteria for either laboratory. Subsequent review of the protocol indicated that contamination was the likely cause of 26 of the 31 erroneous identifications. The results show that the BaSS PCR assay has the potential to be a very reliable screening tool for B. abortus identification. However, the data also provide a cautionary reminder of the importance of preventing contamination in diagnostic PCR.
The incidence of Brucella abortus infections in domestic cattle is at or near 0 in the United States (106th Annual Meeting of the United States Animal Health Association, Report of the Committee on Brucellosis, St. Louis, MO; October 20, 2002). Surveillance procedures need to be continued to prevent reintroduction of the disease into the United States' livestock. The occasional occurrence of seropositive reactions from B. abortus strain S19-vaccinated cattle also confounds the problem because these reactions need to be distinguished from natural infections.
Previously, a rapid multiplex polymerase chain reaction (PCR) test was designed to identify and differentiate 4 Brucella spp: B. abortus (biovars 1, 2, and 4), B. melitensis (biovars 1, 2, and 3), B. ovis, and B. suis (biovar 1). 2, 3 This assay was subsequently named the AMOS assay for the 4 species it identified. An abbreviated form of the assay was developed specifically for cattle isolates, which was designed to identify and differentiate B. abortus field strains (biovars 1, 2, and 4) and the 2 certified vaccine strains (S19 and RB51) from other species of Brucella (usually B. suis in the United States) and from bacteria not belonging to the genus Brucella. This test was evaluated in the diagnostic laboratory setting and found to be an effective first screen for diagnosis of brucellosis. 4 Subsequently, it was noted that deviations in the protocol or the quality and concentration of the samples (espe-From the USDA Agricultural Research Service, National Animal Disease Center, 2300 Dayton Road, Ames, IA 50010 (Bricker, Olsen, Jensen), and the USDA Animal and Plant Health Inspection Service, National Veterinary Services Laboratories, 1800 Dayton Road, Ames, IA 50010 (Ewalt) . cially non-Brucella bacteria) occasionally resulted in misidentifications.
In response to these concerns, the assay was reformulated and reoptimized. 5 Several primers were lengthened or redesigned, and an internal control was introduced. This improved assay, renamed the B. abortus species-specific (BaSS) PCR assay, was designed to identify bovine brucellosis in cattle in the United States. As in its predecessor, this assay was designed to specifically recognize field strains of B. abortus biovars 1, 2, and 4 (the only biovars occurring in the United States) and to distinguish these from vaccine strains and from other Brucella species that might occur in cattle. The assay can also distinguish Brucella from a diverse array of other bacteria that could contaminate bovine samples.
To evaluate the reformulated assay, a randomized 334-sample blind test was set up with 80 bacterial isolates (Table 1 ) from the Brucella Culture Collection at the National Animal Disease Center, Ames, IA. Cultured bacteria 1 were harvested in saline, washed, and roughly standardized to 2.0 OD at 600-nm wavelength. a To assess the effects of fixation on assay performance, half the isolates were fully viable, infectious organisms and the other half were fixed in methanol by the addition of 2 parts of methanol (final concentration, 66.6% methanol/33.3% saline) followed by incubation at 4 C for 1 week. Methanol fixation was incorporated into the protocol because Brucella are pathogenic to humans and because fixation preserves the DNA for long-term storage.
Identical sets of the 334 randomized samples were given to 2 laboratories for testing and identification. The isolates were identified only by number. The vi- 
ability status of each sample was unknown to the investigators performing the assays. Reaction tubes containing the PCR reagents were prepared in large batches and provided to each laboratory and stored at Ϫ20 C until needed. Each target was amplified in a 25-l volume consisting of 1ϫ PCR reaction buffer (50 mM Tris, 1.5 mM MgCl 2 , 10 mM KCl, 50 mM (NH 4 ) 2 SO 4 , pH 8.3) b ; 0.2 mM each of deoxyadenosine triphosphate, deoxycytidine triphosphate, deoxyguanosine triphosphate, and deoxythymidine triphosphate; 0.2 M of each of the 7 oligonucleotide primers ( Table 2) ; 1ϫ GC-rich solution b ; and 1.0 units of the DNA polymerase. b The success of the assay varies greatly with the polymerase chosen for amplification. The use of a ''hot start'' protocol increases the specificity of amplification. However, because of the selective amplification of targets by AmpliTaq Gold, c this polymerase is not recommended for the assay.
Immediately before testing, the unidentified bacterial samples were diluted 1:10 (vol/vol) in distilled water, and a 5-l aliquot was added directly to the liquid in the microtube. The cycling parameters were: 95 C for 5 minutes (to lyse a portion of the intact bacteria and to activate the modified polymerase), followed by 40 cycles of 95 C for 15 seconds, 52 C for 30 seconds, and 72 C for 90 seconds. d The reactions were stored at 4 C until the amplified products were separated on a 2% agarose gel in 0.5ϫ TBE (44.6 mM Tris, 44.5 mM boric acid, 1 mM ethylenediaminetetraacetic acid; pH 8.3). The DNA bands were observed by UV fluorescence in the presence of ethidium bromide and photographed.
Identification was based on the size and number of DNA products that are amplified from each isolate. By design, the multiplex assay involves targets at 4 different loci: 1) a target amplified from the 16S locus (internal control); 2) a target amplified from the alkB locus 2 (B. abortus specific); 3) a target amplified from the wboA locus 3,8 (specific for B. abortus strain RB51); and 4) a target amplified from the eryCD locus 3,6,7 (common to all Brucella except B. abortus strain 19). Thus, the BaSS PCR assay provides 5 possible outcomes for an isolate, and up to 4 products can be simultaneously amplified ( Table 3) . A sample of the data is shown in Fig. 1 . Of the 334 isolates analyzed by each laboratory, 168 were B. abortus field strains (wild type), 12 were strain S19 isolates, 26 were strain RB51 isolates, 60 were non-abortus Brucella species, and 68 were non-Brucella bacteria that might contaminate bovine samples. The sensitivity of the BaSS PCR assay was calculated for each possible outcome. Because there was a significant difference in the results obtained from the 2 laboratories involved, the individual data as well as the combined data are presented in Table 4 . In laboratory 1, the sensitivity of the assay ranged from 66.7% for strain S19 to 100% for strain RB51. Laboratory 2 identified all the isolates correctly; thus, the sensitivity was 100% for each category. The specificity of the assay for laboratory 1 ranged from 93.2% for non-abortus Brucella to 99.7% for strain S19 (Table 5 ). Because laboratory 2 identified all the isolates correctly, the specificity was 100% for each category.
The predictive values of the assay were also variable ( Table 6) , ranging from 77.3% for Brucella species to 98.2% for B. abortus wild type (biovars 1, 2, and 4) in laboratory 1. The predictive values for laboratory 2 were 100% in all categories. Slightly more than half the isolates misidentified by laboratory 1 were viable bacteria, but there was no pattern in the distribution of live versus fixed bacteria among categories.
Laboratory 1 misidentified a total of 31 isolates. The breakdown for the incorrect identification by category is shown in Table 7 . Misidentification was not random among the categories. The greatest number of errors was for the identification of non-Brucella bacteria as Brucella spp. or RB51 (22 of the 31 errors). None of the RB51 isolates were misidentified. Furthermore, none of the B. abortus strain 2308, the parental strain of RB51, were misidentified. The potential value of the assay as a diagnostic screening tool is indicated by the 100% predictive value for all categories by laboratory 2. However, the large numbers of samples misidentified by laboratory 1 is a cause for concern.
It was noted that 26 of the 31 erroneous samples were identified on the basis of at least 1 additional amplified product not usually associated with the target. Also, most of the misidentified samples were clustered by the sequence in which they were tested. The simplest explanation for this result is the contamination of samples before amplification. As in any diagnostic PCR assay, contamination is a major concern because as little as 1 copy of amplified product or source material can provide enough target material for amplification.
A review of the protocol revealed that although precautions were in place to prevent contamination during preparation of the reaction mixture and amplification, a problem was discovered with the technique used by laboratory 1 for sample preparation. The unprotected barrel of the automatic pipettor (above the disposable tip) was entering the source tube during dilution of the sample before amplification. The source tube contained a narrow, screw-type orifice, so the potential for the transfer of bacteria to the pipette barrel and back to another sample tube was high. This is the most likely source of contamination and the cause for most of the misidentifications. Contamination would also explain why retesting the majority of the erroneous samples resulted in the same misidentification of each sample. The BaSS PCR assay is a rapid, inexpensive method for screening bovine-derived bacteria to identify Brucella. The 100% success rate for laboratory 2 demonstrates that the assay has the potential to be both accurate and sensitive as a diagnostic aid. However, the experience of laboratory 1 should serve as a strong reminder that extreme caution must be exercised to avoid contamination artifacts with diagnostic PCR. 
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